Compound Detail
CHEMBL4110064
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4110064 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XVHYCTRAHRTVIP-OAHLLOKOSA-N |
1
Targets
6
Activities
2
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
418.5
MW (Da)
3.93
ALogP
7
HBA
0
HBD
68.8
PSA (Ų)
0.51
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 4 meas. best 7.17
IC50 2 meas. best 7.43
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Neuromedin-K receptor CHEMBL4429 | IC50 | 7.43 | 7.43 | 37.0 | 2 |
| Neuromedin-K receptor CHEMBL4429 | Ki | 7.17 | 7.17 | 68.0 | 4 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Neuromedin-K receptor | IC50 | = | 37.0 | nM | 7.43 | Aequorin Functional Assay: Changes in intracellular calcium levels are a recogni... | - |
| Neuromedin-K receptor | IC50 | = | 37.0 | nM | 7.43 | Aequorin Assay with Human NK-3 Receptor: The antagonist activity of compounds of... | - |
| Neuromedin-K receptor | Ki | = | 68.0 | nM | 7.17 | Binding Competition Assay: The ability of compounds of the invention to inhibit ... | - |
| Neuromedin-K receptor | Ki | = | 68.0 | nM | 7.17 | Aequorin Assay with Human NK-3 Receptor: The antagonist activity of compounds of... | - |
| Neuromedin-K receptor | Ki | = | 68.0 | nM | 7.17 | Competitive Binding Assay: NK3: The ability of compounds of the invention to inh... | - |
| Neuromedin-K receptor | Ki | = | 68.0 | nM | 7.17 | Binding Competition Assay: NK3: The ability of compounds of the invention to inh... | - |
Data from ChEMBL 36 via Core Engine